全球药品契约製造、研究及包装市场

全球药品契约製造、研究和包装市场规模预计将从 2023 年的 2,122 亿美元增至 2029 年的 3,102 亿美元，预测期内复合年增长率为 6.7%。

契约製造服务业预计将从 2023 年的 1,236 亿美元增至 2029 年的 1,833 亿美元，复合年增长率为 7.0%。此外，研究服务业预计将从 2023 年的 724 亿美元增至 2029 年的 1,041 亿美元，复合年增长率为 6.3%。

该报告调查了全球药品契约製造、研究和包装市场，并提供了市场概况、市场影响因素和市场机会分析、新兴技术和技术发展趋势、市场规模趋势和预测、各个细分市场和地区。详细分析、竞争格局、主要企业简介等。

目录

第一章执行摘要

• 市场展望
• 调查范围
• 市场概况

第二章 市场概况

• 概述
• 外包的好处
• 外包的缺点
• 契约製造
• 契约製造的类型
• 契约製造评价标准
• 需要持续关注的核心功能领域
• 选择药品製造外包伙伴的一般指标
• 客户或承包商不满意的主要原因
• 合约研究
• 受託研究机构的选择
• 合约包装
• 选择合约包装商时要考虑的重点
• 需要合约包装公司

第三章市场动态

• 市场动态：简介
• 市场驱动因素
• 药品需求有弹性
• 上市速度的重要性
• 过渡到更复杂的口服药物
• 生技药品和细胞/基因治疗市场显着成长
• 对高效能应用程式介面 (HPAPI) 的需求不断增长
• 对学名药和生物相似药的需求增加
• 市场限制因素
• 严格的法规和合规要求
• 生技资金筹措挑战
• 持续的地缘政治紧张局势和供应链风险
• 缺乏熟练人才
• 市场趋势
• CDMO角色：从服务供应商转变为策略伙伴
• 永续性
• 增强集成

第四章新兴科技与发展

• 契约製造
• 数位自动化的使用增加
• 柔性製造
• 连续流製造
• 一次性技术的扩展
• 合约研究
• 创新的测试设计
• 分散式和混合临床试验
• 现实世界的证据
• 增加人工智慧和机器学习的使用
• 功能服务合作模式
• 加速全球罕见疾病研究
• 合约包装
• 永续包装
• 智慧包装

第五章市场区隔分析

• 细分细分
• 契约製造市场：按产品类型
• 药物
• 药品
• 医药市场：依剂型分类
• 製药市场：按药物输送系统类型
• 契约製造市场：按药物分子类型
• 小分子药物
• 生物製药
• 先进的治疗
• 契约製造市场：按地区
• 北美洲
• 欧洲
• 亚太地区
• 其他领域
• 合约研究市场：依功能服务类型
• 药物发现
• 临床前开发
• 临床开发
• 契约製造市场：按治疗领域
• 瘤
• 免疫/发炎
• 神经
• 心血管
• 其他的
• 契约製造市场：按地区
• 北美洲
• 欧洲
• 亚太地区
• 其他领域
• 合约包装市场：依服务类型
• 初级包装
• 二次包装
• 三级包装
• 地域分布
• 合约包装市场：按地区
• 北美洲
• 欧洲
• 亚太地区
• 其他领域

第六章 竞争讯息

• 契约製造
• 概述
• 市场占有率
• 奇美欧经营模式
• 合约研究
• 概述
• 市场占有率
• CRO经营模式
• 合约包装
• 概述
• 最近的併购

第七章 附录

• 调查方法
• 来源
• 缩写词
• 公司简介
• AMCOR PLC
• CATALENT INC.
• CHARLES RIVER LABORATORIES
• ICON PLC
• IQVIA INC.
• LABORATORY CORPORATION OF AMERICA HOLDINGS
• LONZA
• PFIZER INC.
• SCHOTT PHARMA
• THERMO FISHER SCIENTIFIC INC.
• WUXI APPTEC
• WESTROCK CO.

The global market for contract pharmaceutical manufacturing, research and packaging is estimated to increase from $212.2 billion in 2023 to reach $310.2 billion by 2029, at a compound annual growth rate (CAGR) of 6.7% from 2024 through 2029.

The contract manufacturing services market for contract pharmaceutical manufacturing, research and packaging is estimated to increase from $123.6 billion in 2023 to reach $183.3 billion by 2029, at a CAGR of 7.0% from 2024 through 2029.

The contract research services market for contract pharmaceutical manufacturing, research and packaging is estimated to increase from $72.4 billion in 2023 to reach $104.1 billion by 2029, at a CAGR of 6.3% from 2024 through 2029.

Report Scope:

This report aims to provide in-depth knowledge of the global pharmaceutical contract manufacturing, research, and packaging market, both in terms of qualitative and quantitative data, to help readers develop and assess the market landscape business/growth strategies, analyze their market position in the current marketplace, and make informed business decisions regarding pharmaceutical contract manufacturing, research, and packaging. BCC Research estimates market size data for 2023 (the base year) and forecasts values for 2024 through 2029.

The contract manufacturing segment is analyzed by product type, dosage form, drug molecule type, drug delivery technologies, and region.

The contract research market is analyzed based on discovery, preclinical, and clinical research functional services.

The contract packaging market covers primary, secondary, and tertiary packaging. Primary packaging are categorized as bottles and vials, blisters, and others (e.g., prefilled-syringes, inhalers, caps and closures, dosing droppers, labels, and accessories) to analyze the primary packaging market.

Industry growth trends, drivers, restraints, and opportunities in the pharmaceutical contract manufacturing, research, and packaging market are also discussed in detail. The scope of the study is global. BCC Research analyzes each market and its application, new products and advancements, market projections, and market shares.

Report Includes:

• 67 data tables and 41 additional tables
• Analysis of the global markets for pharmaceutical and biopharmaceutical contract manufacturing, research and packaging services
• Analyses of global market trends, with market revenue data from 2022 to 2023, estimates for 2024, forecasts for 2025, and projected CAGRs through 2029
• Estimate of the current market size and revenue prospects of the global market, along with a market share analysis by drug type, dosage form, formulation type, application, and region
• Facts and figures pertaining to the market dynamics, current and emerging technologies, regulations, and the expected impact of macroeconomic factors
• Review of the industry supply chain, using the Porter's Five Forces and PESTLE models, to analyze the prevailing micro- and macro environmental factors
• Overview of ESG developments and sustainability trends in the industry, with a focus on consumer attitudes, companies' ESG score rankings and their ESG practices
• A look at the recent patents
• An analysis of the industry structure, including companies' market shares, alliances, M&A activity and venture funding outlook
• Company profiles of major players within the industry, including Lonza, Thermo Fisher Scientific Inc., WuXi AppTec, Catalent Inc., IQVIA Inc., and ICON plc

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Overview
• Outsourcing Benefits
• Outsourcing Drawbacks
• Contract Manufacturing
• Contract Manufacturing Types
• Criteria for Evaluating a Contract Manufacturer
• Core Functional Areas Requiring Constant Attention
• Common Metrics for Selecting an Outsourcing Partner for Pharmaceutical Manufacturing
• Top Sources of Dissatisfaction of Client or Contract Giver
• Contract Research
• Selecting a Contract Research Organization
• Contract Packaging
• Key Considerations When Choosing a Contract Packager
• Need of a Contract Packager

Chapter 3 Market Dynamics

• Market Dynamics Snapshot
• Market Drivers
• Resilient Pharmaceutical Demand
• Need for Speed to Market
• Shift to More Complex Oral Therapies
• Significant Growth in Biologics and Cell and Gene Therapy Market
• Rising Demand for Highly Potent Application Program Interfaces (HPAPI)s
• Growing Demand for Generics and Biosimilars
• Market Restraints
• Strict Regulations and Compliance Requirements
• Biotech Funding Challenges
• Persistent Geopolitical Tension and Supply Chain Risks
• Shortage of Skilled Personnel
• Market Trends
• Shift in Role of CDMOs from Service Providers to Strategic Partners
• Sustainability
• Increasing Consolidation

Chapter 4 Emerging Technologies and Developments

• Contract Manufacturing
• Increased Use of Digital Automation
• Flexible Manufacturing
• Continuous Flow Manufacturing
• Expansion of Single-Use Technologies
• Contract Research
• Innovative Trial Design
• Decentralized and Hybrid Clinical Trials
• Real World Evidence
• Increased Use of Artificial Intelligence and Machine Learning
• Functional Service Partnership Model
• Accelerating Global Rare Disease Research
• Contract Packaging
• Sustainable Packaging
• Smart Packaging

Chapter 5 Market Segmentation Analysis

• Segmentation Breakdown
• Contract Manufacturing Market by Product Type
• Drug Substances
• Drug Products
• Drug Products Market by Dosage Form Type
• Drug Product Market by Drug Delivery System Type
• Contract Manufacturing Market by Drug Molecule Type
• Small Molecule Drugs
• Biologics
• Advanced Therapies
• Contract Manufacturing Market by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World
• Contract Research Market by Functional Service Type
• Drug Discovery
• Preclinical Development
• Clinical Development
• Contract Research Market by Therapeutic Area
• Oncology
• Immunology and Inflammation
• Neurology
• Cardiovascular
• Others
• Contract Research Market by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World
• Contract Packaging Market by Service Type
• Primary Packaging
• Secondary Packaging
• Tertiary Packaging
• Geographic Breakdown
• Contract Packaging Market by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 6 Competitive Intelligence

• Contract Manufacturing
• Overview
• Market Shares
• CMO Business Models
• Contract Research
• Overview
• Market Shares
• CRO Business Models
• Contract Packaging
• Overview
• Recent Mergers and Acquisition

Chapter 7 Appendix

• Methodology
• Sources
• Acronyms
• Company Profiles
• AMCOR PLC
• CATALENT INC.
• CHARLES RIVER LABORATORIES
• ICON PLC
• IQVIA INC.
• LABORATORY CORPORATION OF AMERICA HOLDINGS
• LONZA
• PFIZER INC.
• SCHOTT PHARMA
• THERMO FISHER SCIENTIFIC INC.
• WUXI APPTEC
• WESTROCK CO.

List of Tables

• Summary Table : Global Market for Contract Pharmaceutical Manufacturing, Research and Packaging, by Segment, Through 2029
• Table 1 : Global Market for Contract Manufacturing Services, by Product Type, Through 2029
• Table 2 : Global Market for Contract Manufacturing of Drug Substances, by Region, Through 2029
• Table 3 : Global Market for Contract Manufacturing of Drug Products, by Dosage Form Type, Through 2029
• Table 4 : Global Market for Contract Manufacturing of Solid Dosage Forms, by Formulation, Through 2029
• Table 5 : Global Market for Contract Manufacturing of Liquid Drug Dosage Forms, by Formulation, Through 2029
• Table 6 : Global Market for Contract Manufacturing of Non-Sterile Liquid Drug Dosage Forms, by Formulation, Through 2029
• Table 7 : Global Market for Contract Manufacturing of Sterile Liquid Drug Dosage Forms, by Formulation, Through 2029
• Table 8 : Global Market for Contract Manufacturing of Semi-Solid Dosage Forms, by Formulation, Through 2029
• Table 9 : Global Market for Contract Manufacturing, by Drug Delivery System Type, Through 2029
• Table 10 : Global Market for Contract Manufacturing of Advanced Drug Delivery Systems, by Technology, Through 2029
• Table 11 : Global Market for Contract Pharmaceutical Manufacturing, by Drug Molecule Type, Through 2029
• Table 12 : Global Market for Contract Pharmaceutical Manufacturing, by Region, Through 2029
• Table 13 : North American Market for Contract Pharmaceutical Manufacturing, by Country, Through 2029
• Table 14 : North American Market for Contract Pharmaceutical Manufacturing, by Product Type, Through 2029
• Table 15 : North American Market for Contract Manufacturing of Drug Products, by Dosage Form Type, Through 2029
• Table 16 : North American Market for Contract Manufacturing of Liquid Drug Dosage Forms, by Formulation, Through 2029
• Table 17 : North American Market for Contract Manufacturing of Drug Products, by Drug Delivery System Type, Through 2029
• Table 18 : European Market for Contract Pharmaceutical Manufacturing, by Country, Through 2029
• Table 19 : European Market for Contract Pharmaceutical Manufacturing, by Product Type, Through 2029
• Table 20 : European Market for Contract Manufacturing of Drug Products, by Dosage Form Type, Through 2029
• Table 21 : European Market for Contract Manufacturing of Liquid Drug Dosage Forms, by Formulation, Through 2029
• Table 22 : European Market for Contract Manufacturing of Drug Products, by Drug Delivery System Type, Through 2029
• Table 23 : Asia-Pacific Market for Contract Pharmaceutical Manufacturing, by Country, Through 2029
• Table 24 : Asia-Pacific Market for Contract Pharmaceutical Manufacturing, by Product Type, Through 2029
• Table 25 : Asia-Pacific Market for Contract Manufacturing of Drug Products, by Dosage Form Type, Through 2029
• Table 26 : Asia-Pacific Market for Contract Manufacturing of Liquid Drug Dosage Forms, by Formulation, Through 2029
• Table 27 : Asia-Pacific Market for Contract Manufacturing of Drug Products, by Drug Delivery System Type, Through 2029
• Table 28 : Rest of the World Market for Contract Pharmaceutical Manufacturing, by Region, Through 2029
• Table 29 : Rest of the World Market for Contract Pharmaceutical Manufacturing, by Product Type, Through 2029
• Table 30 : Rest of the World Market for Contract Manufacturing of Drug Products, by Dosage Form Type, Through 2029
• Table 31 : Rest of the World Market for Contract Manufacturing of Liquid Drug Dosage Forms, by Formulation, Through 2029
• Table 32 : Rest of the World Market for Contract Manufacturing of Drug Products, by Drug Delivery System Type, Through 2029
• Table 33 : Drug Development Process
• Table 34 : Global Market for Contract Research Services, by Functional Service, Through 2029
• Table 35 : Drug Discovery Stages
• Table 36 : Clinical Phase Description
• Table 37 : Global Market for Contract Research Services, by Therapeutic Area, Through 2029
• Table 38 : Global Market for Contract Research Services, by Region, Through 2029
• Table 39 : North American Market for Contract Research Services, by Functional Service, Through 2029
• Table 40 : North American Market for Contract Research Services, by Country, Through 2029
• Table 41 : European Market for Contract Research Services, by Functional Service, Through 2029
• Table 42 : European Market for Contract Research Services, by Country, Through 2029
• Table 43 : Asia-Pacific Market for Contract Research Services, by Functional Service, Through 2029
• Table 44 : Asia-Pacific Market for Contract Research Services, by Country, Through 2029
• Table 45 : Rest of the World Market for Contract Research Services, by Functional Service, Through 2029
• Table 46 : Rest of the World Market for Contract Research Services, by Sub-Region, Through 2029
• Table 47 : Global Market for Contract Pharmaceutical Packaging Services, by Service Type, Through 2029
• Table 48 : Global Market for Primary Contract Pharmaceutical Packaging Services, by Product Type, Through 2029
• Table 49 : Global Market for Contract Pharmaceutical Packaging Services, by Region, Through 2029
• Table 50 : North American Market for Contract Pharmaceutical Packaging Services, by Service Type, Through 2029
• Table 51 : North American Market for Contract Pharmaceutical Packaging Services, by Country, Through 2029
• Table 52 : European Market for Contract Pharmaceutical Packaging Services, by Service Type, Through 2029
• Table 53 : European Market for Contract Pharmaceutical Packaging Services, by Country, Through 2029
• Table 54 : Asia-Pacific Market for Contract Pharmaceutical Packaging Services, by Service Type, Through 2029
• Table 55 : Asia-Pacific Market for Contract Pharmaceutical Packaging Services, by Country, Through 2029
• Table 56 : Rest of the World Market for Contract Pharmaceutical Packaging Services, by Service Type, Through 2029
• Table 57 : Rest of the World Market for Contract Pharmaceutical Packaging Services, by Region, Through 2029
• Table 58 : Selected Mergers and Acquisitions in the Contract Pharmaceutical Research, Manufacturing and Packing Industry, 2022-2024
• Table 59 : Report Sources
• Table 60 : Glossary of Terms Used in Global Market for Contract Pharmaceutical Manufacturing, Research and Packaging
• Table 61 : Amcor Plc: Company Snapshot
• Table 62 : Amcor Plc: Financial Performance, FY 2022 and 2023
• Table 63 : Amcor Plc: Product Portfolio
• Table 64 : Amcor Plc: News/Key Developments, 2022-2024
• Table 65 : Catalent Inc.: Company Snapshot
• Table 66 : Catalent Inc.: Financial Performance, FY 2022 and 2023
• Table 67 : Catalent Inc.: Product Portfolio
• Table 68 : Catalent Inc.: News/Key Developments, 2022-2024
• Table 69 : Charles River Laboratories: Company Snapshot
• Table 70 : Charles River Laboratories: Financial Performance, FY 2022 and 2023
• Table 71 : Charles River Laboratories: Product Portfolio
• Table 72 : Charles River Laboratories: News/Key Developments, 2022-2024
• Table 73 : ICON Plc: Company Snapshot
• Table 74 : ICON Plc: Financial Performance, FY 2022 and 2023
• Table 75 : ICON Plc: Product Portfolio
• Table 76 : ICON Plc: News/Key Developments, 2023 and 2024
• Table 77 : IQVIA Inc.: Company Snapshot
• Table 78 : IQVIA Inc.: Financial Performance, FY 2022 and 2023
• Table 79 : IQVIA Inc.: Product Portfolio
• Table 80 : Laboratory Corporation of America Holdings: Company Snapshot
• Table 81 : Laboratory Corporation of America Holdings: Financial Performance, FY 2022 and 2023
• Table 82 : Laboratory Corporation of America Holdings: Product Portfolio
• Table 83 : Laboratory Corporation of America Holdings: News/Key Developments, 2023 and 2024
• Table 84 : Lonza: Company Snapshot
• Table 85 : Lonza: Financial Performance, FY 2022 and 2023
• Table 86 : Lonza: Product Portfolio
• Table 87 : Lonza: News/Key Developments, 2022-2024
• Table 88 : Pfizer Inc.: Company Snapshot
• Table 89 : Pfizer Inc.: Financial Performance, FY 2022 and 2023
• Table 90 : Pfizer Inc: Product Portfolio
• Table 91 : Pfizer Inc.: News/Key Developments, 2022
• Table 92 : SCHOTT Pharma: Company Snapshot
• Table 93 : SCHOTT Pharma: Financial Performance, FY 2022 and 2023
• Table 94 : SCHOTT Pharma: Product Portfolio
• Table 95 : Table 95 SCHOTT Pharma: News/Key Developments, 2023 and 2024
• Table 96 : Thermo Fisher Scientific Inc.: Company Snapshot
• Table 97 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
• Table 98 : Thermo Fisher Scientific Inc: Product Portfolio
• Table 99 : Thermo Fisher Scientific Inc.: News/Key Developments, 2023 and 2024
• Table 100 : WuXi AppTec: Company Snapshot
• Table 101 : WuXi AppTec Financial Performance, FY 2022 and 2023
• Table 102 : WuXi AppTec: Product Portfolio
• Table 103 : WuXi AppTec: News/Key Developments, 2022-2024
• Table 104 : WestRock Co.: Company Snapshot
• Table 105 : WestRock Co. Financial Performance, FY 2022 and 2023
• Table 106 : WestRock Co.: Product Portfolio
• Table 107 : WestRock Co.: News/Key Developments, 2022-2024

List of Figures

• Summary Figure : Global Market for Contract Pharmaceutical Manufacturing, Research and Packaging, by Segment, 2021-2029
• Figure 1 : CDMO Market Segmentations, by Service, Molecule and End Use
• Figure 2 : Basic CDMO Service
• Figure 3 : Pharmaceutical Research and Development Continuum
• Figure 4 : Market Dynamics of Contract Pharmaceutical Manufacturing, Research and Packaging
• Figure 5 : Drug Approval Timeline
• Figure 6 : Industry Clinical Trial Success Rates, New Molecular Entities Only, 2020
• Figure 7 : Novel FDA-Approved Drugs, by Type, 2018-2023
• Figure 8 : Venture Capital Investment in Biopharma, 2020-2023
• Figure 9 : Pharma 4.0 Benefits to Pharmaceutical Companies
• Figure 10 : Global Market Shares of Contract Manufacturing Services, by Product Type, 2023
• Figure 11 : Global Market Shares of Contract Manufacturing of Drug Substances, by Region, 2023
• Figure 12 : Global Market Shares of Contract Manufacturing, by Drug Delivery System Type, 2023
• Figure 13 : Global Market Shares of Contract Manufacturing of Advanced Drug Delivery Systems, by Technology, 2023
• Figure 14 : Advanced Drug Delivery Systems, by Technology
• Figure 15 : Conventional vs. Advanced Dosage Forms
• Figure 16 : Global Market Shares of Contract Pharmaceutical Manufacturing, by Drug Molecule Type, 2023
• Figure 17 : Global Market for Contract Pharmaceutical Manufacturing, by Region, 2021-2029
• Figure 18 : Global Market Shares of Contract Pharmaceutical Manufacturing, by Region, 2023
• Figure 19 : Distribution Share of R&D Investment in Drug Development, by Function, 2020
• Figure 20 : Global Market Shares of Contract Research Services, by Functional Service, 2023
• Figure 21 : Clinical Development Services Offered, by CROs
• Figure 22 : Global Market Shares of Contract Research Services, by Therapeutic Area, 2023
• Figure 23 : Global Market Shares of Contract Research Services, by Region, 2023
• Figure 24 : Share of Clinical Trials Started from 2019 through 2023, by Region
• Figure 25 : Global Market Shares of Contract Pharmaceutical Packaging Services, by Service Type, 2023
• Figure 26 : Global Market Shares of Contract Pharmaceutical Packaging Services, by Region, 2023
• Figure 27 : Global Market Shares of Contract Manufacturing Services, by Top Companies, 2023
• Figure 28 : CMO Business Models
• Figure 29 : Global Market Shares of Contract Research Services, by Top Companies, 2023
• Figure 30 : CRO Business Models
• Figure 31 : Amcor Plc: Revenue Share, by Business Unit, FY 2023
• Figure 32 : Amcor Plc: Revenue Share, by Region, FY 2023
• Figure 33 : Catalent Inc.: Revenue Share, by Business Unit, FY 2023
• Figure 34 : Catalent Inc.: Revenue Share, by Country/Region, FY 2023
• Figure 35 : Charles River Laboratories: Revenue Share, by Business Unit, FY 2023
• Figure 36 : Charles River Laboratories: Revenue Share, by Country/Region, FY 2023
• Figure 37 : ICON Plc: Revenue Share, by Country/Region, 2023
• Figure 38 : IQVIA Inc.: Revenue Share, by Business Unit, 2023
• Figure 39 : IQVIA Inc.: Revenue Share, by Region, 2023
• Figure 40 : Laboratory Corporation of America Holdings: Revenue Share, by Business Unit, 2023
• Figure 41 : Laboratory Corporation of America Holdings: Revenue Share, by Region, 2023
• Figure 42 : Lonza: Revenue Share, by Business Unit, FY 2023
• Figure 43 : Lonza: Revenue Share, by Region, FY 2023
• Figure 44 : Pfizer Inc.: Revenue Share, by Business Unit, 2023
• Figure 45 : Pfizer Inc.: Revenue Share, by Country/Region, 2023
• Figure 46 : SCHOTT Pharma: Revenue Share, by Business Unit, 2023
• Figure 47 : SCHOTT Pharma: Revenue Share, by Region, 2023
• Figure 48 : Thermo Fisher Scientific Inc.: Market Share, by Business Unit, 2023
• Figure 49 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, 2023
• Figure 50 : WuXi AppTec: Revenue Share, by Business Unit, FY 2023
• Figure 51 : WuXi AppTec: Revenue Share, by Country/Region, FY 2023
• Figure 52 : WestRock Co.: Revenue Share, by Business Unit, FY 2023
• Figure 53 : WestRock Co.: Revenue Share, by Country/Region, FY 2023